As part of National Teen Driver Safety Week, the National Highway Traffic Safety Administration and the Ad Council announced today their first national public service campaign designed to prevent underage drinking and driving. Following the success of iconic campaigns including “Friends Don’t Let Friends Drive Drunk” and “Buzzed Driving is Drunk Driving,” the new public service ads (PSAs) were unveiled this morning by Mark Rosekind, Administrator for the U.S. Department of Transportation’s National Highway Traffic Safety Administration (NHTSA), at the National Organizations for Youth Safety (NOYS) Teen Safe Driving Summit in Washington, DC.
“One teenage death from drinking and driving is too many,” said NHTSA Administrator Mark Rosekind. “Our goal with this campaign is to raise awareness among teenagers that drinking and driving is one of the worst mistakes they can ever make, with deadly consequences that can’t be undone.”
Motor vehicle crashes are the leading cause of death among teens in America, and almost half of teens killed in crashes are the drivers themselves. Despite a minimum legal drinking age of 21 in all 50 states, almost one-quarter of young drivers involved in fatal traffic crashes had alcohol in their systems according to data from NHTSA.
To view the multimedia release go to:
http://www.multivu.com/players/English/7662551-ad-council-ultimate-party-foul/
Quinny and Maxi-Cosi, premier European brands of Dorel Juvenile, a segment of Dorel Industries (TSX: DII.B, DII.A), and the world's largest juvenile products manufacturer in its categories, today announced its most luxurious collection yet, launching globally, from renowned designer, stylist and editor Rachel Zoe. Rachel Zoe x Quinny and Maxi-Cosi merges the brands’ design-forward, high quality and industry leading safety with Zoe’s unparalleled, award-winning fashion sensibility.
“We’re proud to collaborate with a designer of Rachel Zoe’s caliber,” said Dan Pennacchio, General Manager of Premium Brands at Dorel Juvenile USA. “Our partnership with Rachel once again asserts our expertise in providing style-conscious parents with the latest in designer baby gear. Her insights into the worlds of design and motherhood are captured in the collection’s chic, yet classic and functional aesthetic.”
With nearly two decades of experience in design and fashion, Zoe has become a household name embodying sophisticated, timeless style and Hollywood glamour. From designing her eponymous collection, and authoring two New York Times bestselling books, to acting as Editor-in-Chief of digital style destination The Zoe Report, and most recently returning to TV with Lifetime’s “Fashionably Late with Rachel Zoe,” her influence continues to grow. A mom to two young sons, Zoe’s recent, highly-acclaimed maternity wear collection for A Pea in the Pod exemplifies her ever-expanding appeal to women everywhere.
To view the multimedia release go to:
http://www.multivu.com/players/English/7662251-rachel-zoe-quinny-maxi-cosi/
Call it a homecoming.
When Toyota introduced Lexus to the U.S. market in 1989, the Georgetown, Ky., plant – its first stand-alone vehicle manufacturing facility in America – was just in its second year of producing the Camry.
Fast forward 26 years and that same plant is celebrating the start of U.S. Lexus production. Today at a ceremony fit for a luxury brand king, the first-ever U.S.-produced ES 350 was unveiled before several thousand proud team members in Georgetown. And, just like a newborn foal at the nearby horse farms in Central Kentucky, the newcomer was brought into the world with plenty of TLC and hope for a bright future.
“This is really a proud moment for us and brings us full circle,” said Wil James, president, Toyota Motor Manufacturing, Kentucky, Inc. “To be the first wholly owned plant, building the number one best-selling car in America, the Camry, for 13 years in a row, and then to be selected to build the first Lexus is truly a tribute to our team members.”
For the past two and a half years, the Kentucky plant – Toyota’s largest in North America – has been gearing up to make the ES 350, Lexus’ best-selling sedan in the U.S. In all, $360 million was invested toward a new dedicated assembly line, adding 750 new jobs. Total capacity for the new line will be 50,000 vehicles.
To view the multimedia release go to:
http://www.multivu.com/players/English/7655351-lexus-kentucky-plant-es-350/
In order to succeed in today’s B2B sales world, salespeople must create buyer consensus among diverse customer stakeholders. Those who fail to do that risk falling victim to the status-quo – the minimal-risk, lowest-cost option – or worse, losing the deal altogether. The Challenger Customer: Selling to the Hidden Influencer Who Can Multiply Your Results from CEB (NYSE: CEB), a best practice insight and technology company, reveals that it isn’t just about how you engage, but who you engage within the customer organization that drives complex sales today.
“The ‘senior decision-maker’ no longer exists in B2B sales. That makes the most significant problem facing marketing and sales teams a buying problem, not a selling problem. Organizations need to shift their focus from making the sale to understanding buyer groups – and who among them really shapes decisions,” said co-author Brent Adamson, executive advisor at CEB. “Our research shows that the one thing that matters most to executives is whether or not a supplier has buy-in with the rest of the organization – NOT the supplier’s actual offering or solution.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7427252-ceb-the-challenger-customer/
Pivotal Corporation, the Seattle start-up responsible for disrupting the wearable fitness marketplace with its $12 Pivotal Living Band, is pleased to announce pre-order availability for the Pivotal Living Smart Scale, a smarter scale with an even smarter price. Available for $39.95, just a fraction of the cost of most smart scales on the market, the elegant and efficient smart scale integrates seamlessly with the Pivotal Living app to provide a more intelligent way to manage body weight and overall health.
“Our mission has always been to spark a movement toward proactive health and wellness through affordable and powerful, personal health technology,” said David Donovick, CEO for Pivotal Corporation. “We are very proud to introduce a feature-rich smart scale to our family of products and software, and are thrilled to be able to offer it to our members at a pizza-dinner price!”
Using advanced bioimpedance technology, the Pivotal Living Smart Scale accurately measures key body weight and body fat percentage factors, helping people lose weight and stay healthy. Designed to help users identify when they are burning fat, building muscle and losing weight, the sleek smart scale displays weight on the scale’s easy-to-read LCD display screen and, when synced to the Pivotal Living mobile app, sends additional weight and body details. The scale’s four load sensors accurately assess body composition measurements based on weight and height data stored within the app. Working together, the scale and app measure and track.
To view the multimedia release go to:
http://www.multivu.com/players/English/7668051-pivotal-living-bluetooth-smart-scale/
The Amgen Foundation announced today that it will invest more than $4 million to support and strengthen the Amgen Biotech Experience program across the United States, Puerto Rico, United Kingdom and Ireland. The Amgen Biotech Experience includes an engaging series of labs that effectively bring biotechnology into classrooms. This new commitment will also strengthen the program’s alignment with the United States’ Next Generation Science Standards, which are focused on engaging students in more authentic science learning experiences. With the support of Education Development Center, Inc. (EDC), the global nonprofit leading the Amgen Biotech Experience Program Office, the investment is expected to empower 1,000 teachers who will reach more than 150,000 new students with the labs over the next two years.
“We are very excited to extend our commitment to the Amgen Biotech Experience, a program that began 25 years ago, with the intent to ignite a deep passion for innovation and scientific discovery in students,” said Robert A. Bradway, chairman and chief executive officer of Amgen. “This program, which provides advanced biotech curriculum and professional-grade lab equipment at no cost to schools, has opened countless students’ eyes to the world of biotechnology, fueling potential long term advancements to both medicine and society.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7414055-amgen-biotech-experience-grant/
Blood is an essential component for life, but many people do not think about it until the need is critical. Each year 234 million major operations are performed worldwide, many involving blood transfusions or treatments resulting in a continuous need for donations.
That’s why Abbott (NYSE: ABT) and Real Madrid soccer star Cristiano Ronaldo are partnering to bring even more attention to this important cause. Regarded as one of the top soccer players in the world, Ronaldo will serve as the first global ambassador for the BE THE 1™ movement – developed to inspire young people around the world to regularly donate blood.
“We can all make a difference by donating blood. Each donation can benefit up to three people in emergency situations and for long-term medical treatments,” said Cristiano Ronaldo, forward for Real Madrid and Captain for Portugal National Football. “That’s why I am enthusiastic to be partnering with Abbott to bring awareness to the importance of blood donation and to encourage people around the world to become lifelong blood donors and help save lives.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7668251-abbott-cristiano-ronaldo-donate-blood/
Carbone, the Greenwich Village sensation that made waves in New York City’s dining scene, made its debut in the entertainment capital of the world last night as it officially opened its doors at ARIA Resort & Casino in Las Vegas.
Marking Major Food Group’s first domestic expansion outside of New York City, Mario Carbone, Rich Torrisi and Jeff Zalaznick introduce their celebrated concept to Las Vegas that reinvigorates classic Italian-American cuisine with unforgettable Captain tableside service, world-class-sourced ingredients, and award-winning culinary craftsmanship.
“The glamour, history and attitude of Las Vegas make it a perfect fit for Carbone,” said Jeff Zalaznick, managing partner. “We are not just replicating the New York City restaurant; our guests will experience a Carbone specifically for Las Vegas.”
Chef-partner Mario Carbone said, “It is very exciting to be a part of the booming food scene happening on the Las Vegas Strip. We are committed to bringing Las Vegas a truly memorable dining experience that is unlike anything this city has seen.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7655751-carbone-las-vegas-strip-aria-resort/
Today, SunPower launched its Helix™ platform, the world’s first fully-integrated commercial solar solution combining solar power production and energy management.
“Unique in the solar industry, Helix is a complete solution that optimizes power production and maximizes value for our commercial customers, such as Bed Bath and Beyond,” said Tom Werner, president and CEO of SunPower. “Integral to each Helix component, from the solar cells to the energy management system, is SunPower’s 30 years of innovation and experience delivering some of the world’s most efficient, reliable solar technology.”
Helix is a pre-engineered, modular solution that is built to last and fast to install, enabling customers to scale their solar programs quickly with minimal business disruption. The Helix platform is standardized across rooftop, carport and ground installations.
To view the multimedia release go to:
http://www.multivu.com/players/English/7048952-sunpower-helix/
Toys“R”Us® today announced that The Great Big Toys“R”Us Book of Awesome, the company’s annual resource for the year’s hottest toys, will begin arriving in homes this week featuring an all-new, special interactive edition. This 96-page toy compendium is compatible with the company’s all-new app, The Geoffrey Shuffle, a game that allows kids to bring to life the season’s most coveted toys through an augmented reality experience. An abbreviated catalog, which features 48 pages of kid-favorite toys, is now available online at Toysrus.com and will be in local newspapers on Saturday, October 31. This year’s highly-anticipated gift guide from The World’s Greatest Toy Store™ also includes thousands of dollars worth of compelling deals and coupon offers, valid Sunday, November 1 through Saturday, November 21.
“The arrival of The Great Big Toys“R”Us Book of Awesome marks the kickoff of the time-honored tradition of children eagerly studying pages upon pages of the year’s hottest toys, curating their must-have lists for Christmas morning,” said Richard Lennox, Senior Vice President, Chief Marketing Officer, Toys“R”Us, U.S. “Within the book, we created eight interactive lifestyle spreads that show the breadth of our assortment and make bold statements for some of the brands most beloved by kids. This catalog is the centerpiece of our holiday marketing efforts, and extends the theme of “AWWWESOME,” speaking not only to the excitement kids have when they turn the first page, but also the ways the company is helping gift-givers save with great deals and services, such as Price Match Guarantee and Free Shipping.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7476352-toys-r-us-book-of-awesome-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
